Xenon X-TOLE2/X-ACT/X-TOLE4
(Active, No longer Recruiting)
About the study?
About Study: The Xenon studies are investigating the effect of a novel anti-seizure medication, XEN1101, on seizure frequency for patients diagnosed with Focal or Generalized Epilepsy. Patients will take either the active study drug or the placebo, and have the option to enroll in a long-term extension study after the double-blind period.